Event time: 事件时间:
Published: 文章发布:
Key Results
Actual vs Consensus
EPS: $1.52 vs $1.36 estimate, beat+11.8%.Revenue: $1.6B vs $1.6B estimate, in line+0.5%.Profitability and Cash Flow
Period: 2026 Q3 period ended 2026-09-30Revenue: $1.6B; YoY: +8.9%; QoQ: +0.8%Gross profit: $769M; Gross margin: 47.8%Operating income: $204M; Operating margin: 12.7%; YoY: -16.1%; QoQ: -29.1%Net income: $150M; GAAP diluted EPS: $1.51; YoY: +18.5%; QoQ: -2.6%Operating cash flow: -$576M; Capex: $234M; Free cash flow: -$811MCash: $76M; Total debt: $252M; Net debt: $176MOfficial release: Encompass Health reports results for third quarter 2026
核心结果
实际值与市场预期
EPS:$1.52 vs $1.36 预期,高于预期+11.8%。营收:$1.6B vs $1.6B 预期,基本符合预期+0.5%。财务指标
期间:2026 Q3(截至 2026-09-30)营收:$1.6B;同比:+8.9%;环比:+0.8%毛利润:$769M;毛利率:47.8%经营利润:$204M;经营利润率:12.7%;同比:-16.1%;环比:-29.1%净利润:$150M;GAAP 稀释 EPS:$1.51;同比:+18.5%;环比:-2.6%经营现金流:-$576M;资本开支:$234M;自由现金流:-$811M现金:$76M;总债务:$252M;净债务:$176M